Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Clinical trial NCT01375777 · COMPLETED

Trial details

NCT number

NCT01375777

Sponsor

Amgen

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2011-07-06

Primary completion

2012-03-02

Enrollment

411

View on ClinicalTrials.gov